Cascade-activatable nano-prodrug amplifies ROS-RNS signaling to target NQO1-associated redox vulnerability for melanoma therapy
- DOI
- 10.1186/s12951-026-04825-0
- Published
- 2026-08-03
- Container
- Journal of Nanobiotechnology
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1186/s12951-026-04825-0,
title = {Cascade-activatable nano-prodrug amplifies ROS-RNS signaling to target NQO1-associated redox vulnerability for melanoma therapy},
author = {Honglin Tang and Chongzhi Wu and Wei Wang and Xi Cheng and Yong Dong and Zhiyuan Gao and Pengfei Chen and Xin Xie and Yong Huang and Lihe Sun and Bowen Li and Da Li},
year = {2026},
journal = {Journal of Nanobiotechnology},
doi = {10.1186/s12951-026-04825-0},
url = {https://doi.org/10.1186/s12951-026-04825-0}
}RIS
TY - JOUR TI - Cascade-activatable nano-prodrug amplifies ROS-RNS signaling to target NQO1-associated redox vulnerability for melanoma therapy AU - Honglin Tang AU - Chongzhi Wu AU - Wei Wang AU - Xi Cheng AU - Yong Dong AU - Zhiyuan Gao AU - Pengfei Chen AU - Xin Xie AU - Yong Huang AU - Lihe Sun AU - Bowen Li AU - Da Li PY - 2026 JO - Journal of Nanobiotechnology DO - 10.1186/s12951-026-04825-0 UR - https://doi.org/10.1186/s12951-026-04825-0 ER -
APA
Tang, H., Wu, C., Wang, W., Cheng, X., Dong, Y., Gao, Z., Chen, P., Xie, X., Huang, Y., Sun, L., Li, B., & Li, D. (2026). Cascade-activatable nano-prodrug amplifies ROS-RNS signaling to target NQO1-associated redox vulnerability for melanoma therapy. Journal of Nanobiotechnology. https://doi.org/10.1186/s12951-026-04825-0
Source records
- crossref · retrieved 2026-11-09T03:35:36.776Z